
doi: 10.1248/bpb.32.2057
pmid: 19952428
Hypoxia, which is intimately associated with the biology of breast carcinomas, modulates the level of estrogen receptor (ER) alpha expression and transactivation. We investigated the effect of blocking ER degradation on ERalpha-mediated transactivation under hypoxic conditions using the proteasome inhibitor MG132. Pretreatment with MG132 blocked hypoxia-induced degradation of ERalpha protein. Our data imply that ERalpha proteasomal inhibition is linked to receptor transactivation under hypoxia.
Transcriptional Activation, Leupeptins, Carcinoma, Estrogen Receptor alpha, Antineoplastic Agents, Breast Neoplasms, Cell Line, Tumor, Humans, Female, Hypoxia, Proteasome Inhibitors
Transcriptional Activation, Leupeptins, Carcinoma, Estrogen Receptor alpha, Antineoplastic Agents, Breast Neoplasms, Cell Line, Tumor, Humans, Female, Hypoxia, Proteasome Inhibitors
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
